Literature DB >> 21922459

MRI of localized prostate cancer: coming of age in the PSA era.

Barış Türkbey1, Marcelino Bernardo, Maria J Merino, Bradford J Wood, Peter A Pinto, Peter L Choyke.   

Abstract

Prostate cancer is the most common cancer among American men. It varies widely in aggressiveness, ranging from completely indolent to highly aggressive. Currently, predicting the natural history of a particular tumor and deciding on the appropriate treatment, which might include active surveillance, surgery, radiation or hormonal therapies, are based on the condition and age of the patient as well as the presumed stage of the disease. Imaging plays an important role in staging localized prostate cancer. Magnetic resonance imaging (MRI) best depicts the zonal anatomy, with a superior soft tissue resolution providing better results for tumor localization, monitoring, and local staging. Previously, the major function of prostate MRI has been in staging, and this role remains important. In this article, we introduce the reader to the expanding roles that MRI plays in the management of localized prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21922459      PMCID: PMC6317894          DOI: 10.4261/1305-3825.DIR.4478-11.1

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  64 in total

1.  Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.

Authors:  C S Stewart; B C Leibovich; A L Weaver; M M Lieber
Journal:  J Urol       Date:  2001-07       Impact factor: 7.450

2.  Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium.

Authors:  A W Partin; L A Mangold; D M Lamm; P C Walsh; J I Epstein; J D Pearson
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

3.  Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.

Authors:  M W Kattan; T M Wheeler; P T Scardino
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

4.  Anterior prostate cancer: is it more difficult to diagnose?

Authors:  S R J Bott; M P A Young; M J Kellett; M C Parkinson
Journal:  BJU Int       Date:  2002-06       Impact factor: 5.588

5.  Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?

Authors:  B Djavan; V Ravery; A Zlotta; P Dobronski; M Dobrovits; M Fakhari; C Seitz; M Susani; A Borkowski; L Boccon-Gibod; C C Schulman; M Marberger
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

6.  Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

Authors:  Anthony V D'Amico; Judd Moul; Peter R Carroll; Leon Sun; Deborah Lubeck; Ming-Hui Chen
Journal:  J Clin Oncol       Date:  2003-06-01       Impact factor: 44.544

7.  Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.

Authors:  Deborah A Kuban; Howard D Thames; Larry B Levy; Eric M Horwitz; Patrick A Kupelian; Alvaro A Martinez; Jeff M Michalski; Thomas M Pisansky; Howard M Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-15       Impact factor: 7.038

8.  Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen.

Authors:  Rinaa S Punglia; Anthony V D'Amico; William J Catalona; Kimberly A Roehl; Karen M Kuntz
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

9.  Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.

Authors:  Misop Han; Alan W Partin; Marianna Zahurak; Steven Piantadosi; Johnathan I Epstein; Patrick C Walsh
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

10.  Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging.

Authors:  Tamar Sella; Lawrence H Schwartz; Peter W Swindle; Chinyere N Onyebuchi; Peter T Scardino; Howard I Scher; Hedvig Hricak
Journal:  Radiology       Date:  2004-04-02       Impact factor: 11.105

View more
  13 in total

1.  Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session.

Authors:  Cheng William Hong; Annerleim Walton-Diaz; Soroush Rais-Bahrami; Anthony N Hoang; Barış Türkbey; Lambros Stamatakis; Sheng Xu; Hayet Amalou; M Minhaj Siddiqui; Jeffrey W Nix; Srinivas Vourganti; Maria J Merino; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

Review 2.  Multiparametric MRI and prostate cancer diagnosis and risk stratification.

Authors:  Baris Turkbey; Peter L Choyke
Journal:  Curr Opin Urol       Date:  2012-07       Impact factor: 2.309

3.  Prostate MRI: access to and current practice of prostate MRI in the United States.

Authors:  James L Leake; Rulon Hardman; Vijayanadh Ojili; Ian Thompson; Alampady Shanbhogue; Javier Hernandez; Jelle Barentsz
Journal:  J Am Coll Radiol       Date:  2014-01-02       Impact factor: 5.532

Review 4.  Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia.

Authors:  Brian Garvey; Barış Türkbey; Hong Truong; Marcelino Bernardo; Senthil Periaswamy; Peter L Choyke
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

Review 5.  Active surveillance for prostate cancer: past, present and future.

Authors:  Eric A Singer; Aradhana Kaushal; Baris Turkbey; Anna Couvillon; Peter A Pinto; Howard L Parnes
Journal:  Curr Opin Oncol       Date:  2012-05       Impact factor: 3.645

6.  Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.

Authors:  Shoshana B Ginsburg; Ahmad Algohary; Shivani Pahwa; Vikas Gulani; Lee Ponsky; Hannu J Aronen; Peter J Boström; Maret Böhm; Anne-Maree Haynes; Phillip Brenner; Warick Delprado; James Thompson; Marley Pulbrock; Pekka Taimen; Robert Villani; Phillip Stricker; Ardeshir R Rastinehad; Ivan Jambor; Anant Madabhushi
Journal:  J Magn Reson Imaging       Date:  2016-12-19       Impact factor: 4.813

7.  MR imaging of the prostate and adjacent anatomic structures before, during, and after ejaculation: qualitative and quantitative evaluation.

Authors:  Milica Medved; Steffen Sammet; Ambereen Yousuf; Aytekin Oto
Journal:  Radiology       Date:  2014-02-01       Impact factor: 11.105

Review 8.  Image-guided focal therapy for prostate cancer.

Authors:  Sandeep Sankineni; Bradford J Wood; Soroush Rais-Bahrami; Annerleim Walton Diaz; Anthony N Hoang; Peter A Pinto; Peter L Choyke; Barış Türkbey
Journal:  Diagn Interv Radiol       Date:  2014-11       Impact factor: 2.630

9.  Novel PCA-VIP scheme for ranking MRI protocols and identifying computer-extracted MRI measurements associated with central gland and peripheral zone prostate tumors.

Authors:  Shoshana B Ginsburg; Satish E Viswanath; B Nicolas Bloch; Neil M Rofsky; Elizabeth M Genega; Robert E Lenkinski; Anant Madabhushi
Journal:  J Magn Reson Imaging       Date:  2014-06-18       Impact factor: 4.813

Review 10.  Functional and molecular imaging of localized and recurrent prostate cancer.

Authors:  Kinzya Grant; Maria L Lindenberg; Haytham Shebel; Yuxi Pang; Harsh K Agarwal; Marcelino Bernardo; Karen A Kurdziel; Baris Turkbey; Peter L Choyke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-07       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.